| アブストラクト | Pharmaceutical companies, regulatory agencies, and contract service organizations are managing substantial and ongoing changes to pharmacovigilance legislation in the European Economic Area, and penalties for noncompliance are potentially large. Given that the majority of pharmaceutical companies and contract service organizations have global reach, the impact of this change is being felt far beyond the boundaries of the European Economic Area. |
|---|
| ジャーナル名 | Therapeutic innovation & regulatory science |
|---|
| Pubmed追加日 | 2014/3/1 |
|---|
| 投稿者 | Dollen, Miranda Z |
|---|
| 組織名 | 1 OptumInsight (Canada) Inc, Dundas, ON, Canada. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/30227513/ |
|---|
